(Q33844109)

English

Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy

scientific article

Statements

Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy (English)
5 December 2008
2154-2160

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit